Strong priming of T cells adoptively transferred into scid mice by unknown
BHes Definitive Report 
Strong Priming of T  Cells Adoptively Transferred 
into sdd Mice 
By Geoffrey H. Sunshine, Brad L. Jimmo, Christopher Ianelli, 
and Lesley Jarvis 
From the Department of Surgery, Tufts Unit,ersity School of Veterinary Medicine, Department 
of Pathology, Tufts University School of Me~cine, and the Tufts University Sackler School of 
Graduate Biomedical Sciences, Boston, Massachusetts 02111 
Summary 
We have examined the requirements  for activating unprimed T  cells in vivo by transferring  T 
cells into scid mice, which lack mature B and T  cells.  Purified adult thymocytes and a protein 
antigen, keyhole limpet hemocyanin (KLH), were injected into scid mice. scid mice injected with 
T  cells and KLH developed cellular lymph nodes containing CD4 + and CD8 + T  cells.  Cells 
recovered from the lymph nodes of injected scid mice proliferated and secreted interleukin 2 in 
response to KLH in vitro. The results indicate that T  cells can be primed to KLH in the scid 
mouse in the absence of B cells. 
T 
he question of which APC induces primary T  cell re- 
sponses in vivo is not currently resolved. Several studies, 
in chickens and humans, indicate that B cells are not neces- 
sary for certain T  cell responses. Thus, congenitally B cell- 
deficient  humans  mount  normal  delayed type hypersensi- 
tivity (DTH) responses (1, 2). Furthermore,  bursectomized 
chickens mount normal allograft and DTH responses (3), and 
can prime T cells specific for SRBC (4). Moreover, antigen- 
pulsed dendritic cells, but not B cells, prime mice to protein 
antigens (5). These findings, however, do not rule out a role 
for B cells in events subsequent to the initial priming events. 
The involvement of B cells in events distal to the initial priming 
has been suggested by Ron and Sprent  (6), who observed 
some priming of helper cells in mice chronically treated with 
anti-#  antibodies.  These authors proposed that B cells am- 
plify T cell responses initiated by dendritic cells. In contrast, 
other studies have indicated an apparently essential role for 
B cells in T cell priming. Lymph node cells from mice depleted 
of B lymphocytes by treatment with anti-# antibodies or by 
x-irradiation  failed to make secondary responses to protein 
antigens (7-10). Similarly,  cells from a set of transgenic mice, 
expressing an MHC class  II E  molecule normally in APC 
but in  only 2%  of the animals'  B cells,  did not  mount  a 
proliferative response to an E-restricted antigen  (11). None 
of these studies, however, looked directly at the status of den- 
dritic  cells  in these mice. 
The scid mouse offers a distinct experimental approach to 
study APC function for T  cell priming since these mice are 
known to have APC function in vitro (11), but lack mature 
B and T  cells. By adoptively transferring unprimed T  cells, 
in the presence or absence of injected B cells, into scid mice 
and subsequently priming the mice with KLH, we show that 
endogenous APC are sufficient to prime the T  cells to an- 
tigen in vivo, judged by several criteria. Our results indicate 
that T cell priming in scid mice does not require mature B cells. 
Materials  and Methods 
Mice.  C.B-17 scid mice, originally the generous gift of Dr. Mel 
Bosma, (Fox Chase Cancer Center, Philadelphia, PA), were bred 
and maintained under sterile conditions in the Animal Colony of 
the Tufts University Medical School. scid mice determined to have 
circulating levels of IgM or IgG >5 #g/ml were considered leaky 
and were not used in the study. 4-5-wk old female BALB/c mice 
were obtained  from Jackson  Laboratory, (Bar Harbor,  ME) and 
Taconic Farms, Inc. (Germantown, NY) and maintained in the same 
animal colony under specific pathogen free conditions. 
Antigens.  KLH, Con A, LPS from Escherichia coli 0111:B4, and 
OVA were purchased from Sigma Chemical Co., St. Louis, MO. 
Reconstitution and Priming.  Thymocyte suspensions were pre- 
pared from 6-8-wk-old normal BALB/c mice. Thymocytes were 
passed twice over nylon wool columns. 4-7-wk-old scid mice were 
injected with  15-40  x  l& thymocytes  (scidTav) per site in the 
footpad, base of the tail, and intraperitoneaUy. In some experiments, 
mice were injected with BALB/c spleen cells, treated with anti- 
Thyl.2 and rabbit c, and thymocytes. These T cell-depleted spleen 
cell populations  failed to respond to Con A and showed an en- 
hanced response to LPS compared with untreated spleen cells. Such 
cells are subsequently referred to as B cells. I d later all reconstituted 
scid mice, uninjected scid mice, and a BALB/c control were primed 
in the same sites with 10 #g KLH in CFA. 
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lymph nodes were removed and single-cell  suspensions were pre- 
pared in RPMI 1640,  supplemented as previously described (13), 
but containing 1% heat-inactivated autologous serum rather then 
FCS.  3  x  10  s lymph node cells were cultured in 3-6-well repli- 
cates with 50/zg/ml KLH, 50/zg/ml OVA, or 2.5 #g/ml Con A 
in 200 #1. Supernatant was removed after 18-24 h for cytokine bio- 
assay (13).  For the cytokine bioassay,  8  x  10  ~ CTLL  cells were 
incubated with two to three dilutions  of supernatants for 36 h. 
1 #Ci [3H]TdR was added for the final 18 h. Standard  curves were 
set up with recombinant II:2 and IL4. The presence of ID2 and 
Ib4 in the supernatants of antigen-activated cells was assessed as 
follows: antibodies $4B6 and 11Bll, specific for IL-2 and IL-4, respec- 
tively, were added to supernatants  and assayed on the indicator CTLL 
population, as described above.  The specificity  of the antibodies 
was confirmed in our studies by using recombinant mouse inter- 
leukins. 
FACS |  Analysis.  Conjugated antibodies were diluted to op- 
timal concentrations and centrifuged for 15 min at 10,000 g. 2-10 
x  105 cells were incubated for 30 rain at 4~  with the following 
FITC-conjugated antibodies: F(ab')2 goat anti-mouse IgG (H  + 
L) (Cappel Laboratories, Cochranville, PA),  hamster anti-mouse 
CD3 e (Boehringer Mannheim Diagnostics, Inc., Houston TX), 
and anti-mouse Lyt2 from Becton Dickinson and Co., Mountain 
View,  CA. Phycoerythrin-conjugated anti-mouse L3T4 was also 
used (Becton Dickinson and Co.). The cells were washed in PBS 
containinxg  1%  normal  rabbit  serum  and  then  analyzed  on  a 
FACScan *  (Becton Dickinson and Co.). 
Serum Antibody Levels.  Immulon 2 96-well plates (Dynatech 
Corp., ChantiUy, VA) were coated overnight at 4~  with 1/,g/well 
of either goat anti-mouse IgG, Fc-specific or goat anti-mouse IgM, 
/z chain specific (Sigma Chemical Co., St. Louis, MO), at pH 8.6. 
After extensive washing with PBS, pH 7.4,  plus  1% Tween 20, 
the wells  were incubated for 8 h at room temperature with 3% 
BSA, pH 7.4.  Duplicate wells  were then incubated overnight at 
4~  with doubling dilutions of mouse IgG 2a (r) or mouse IgM 
(r), both from Sigma Chemical Co., or sera from injected mice. 
Wells were then incubated for 6 h at room temperature with 1:1,000 
dilutions  of Sigma alkaline pbosphatase-conjugated anti-mouse IgG 
(whole molecule) or anti-mouse IgM (# chain specific). Solution 
containing Sigma 104 substrate tablets (5 mg/5 ml sodium car- 
bonate buffer, pH 9.5) and 2 mM magnesium chloride was added 
to all wells. Plates were read on a Dynatech MR 650,  at 410 nm, 
after 60-min incubation  at room temperature. 
Results and Discussion 
We first established the phenotype and function of the cells 
that we were to inject into the scid mice. FACS  |  analysis in- 
dicated that thymocytes, treated as described in Materials and 
Methods,  showed an insignificant  level of staining with all 
B  cell-specific reagents;  T  cell staining with anti-CD3  was 
>98%  (data not shown). The proliferative response of these 
purified  thymocytes to both  KLH and  the B  cell mitogen 
LPS was extremely low,  even in  the presence of 2,000  tad 
irradiated BALB/c spleen cells. Supernatants from wells con- 
taining KLH and purified thymocytes, in the presence or ab- 
sence of irradiated spleen cells, did not activate CTLL (data 
not  shown).  Thus,  all these data indicate  that  (a)  the level 
of B cell contamination in the injected T cell population was 
very low, and (b) the ceUs were not previously primed to KLH. 
Table  1.  Supernatants of Lymph Node Cells from scid Mice Reconstituted with  Thymocytes Alone or Thymocytes Plus B  Cells, 
and Injected with KLH,  Contain IL-2 
IL-2 
Exp.  1  -  OVA  Con A  KLH 
U/ml 
BALB/c  <0.01  <0.01  >1.0  0.490  •  0.070 
scidTnv  <0.01  <0.01  >1.0  0.193  •  0.041 
scidTHY+SOa  <0.01  ND  >1.0  0.138  •  0.014 
scidTHv+tSB  <0.01  ND  >1.0  0.153  •  0.016 
scid~Hv+sB  <0.01  <0.01  >1.0  0.136  _+  0.011 
scid  <0.01  <0.01  0.025  +  0.018  <0.01 
KLH-restimulated supernatants 
Exp.  2  -  + Anti-IL-2  + Anti-IL-4 
U/ml 
BALB/c  0.634  •  0.089  <0.01  0.606  •  0.058 
scid~Hv  0.236  •  0.034  <0.01  0.252  •  0.024 
scidT.v+toB  0.205  •  0.022  <0.01  0.218  +_  0.013 
In Exp. 1, scid mice were injected with 100  x  106 thymocytes and in Exp. 2, 70  x  106 thymocytes plus the indicated numbers of B cells in mil- 
lions. The scid control in Exp. 1 is the supernatant of spleen cells from scid mice injected with KLH alone. The anti-IL-4 used in Exp. 2 inhibited 
the activity of 12.5 U/ml recombinant IL-4. 
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Figure 1.  FACS  |  profiles of  lymph  node  cells from (/I) a KLH-primed 
BALB/c mouse, (B) scid mice injected  with KLH and 100 x 106 treated 
thymocytes  and (C) scid mice injected  with KLH, 100 x 10" thymocytes, 
and 15  x 10" B cells. (D) The staining  of spleen cells from a scid mouse 
injected with KLH alone. Cells in I, III, V, and VII were stained for B 
cells with FITC-conjugated  F(ab')2 goat anti-mouse  IgG (H + L). Cells 
in II, IV, VI, and Vlllwere stained  for CD4 § and CD8 + cells  with both 
phycoerythrin-conjugated  anti-L3T4 and FlTC-anti-mouse Lyt 2. 
9 d  after injecting antigen -  (10 d  after injecting cells) 
draining lymph nodes and spleens were removed, scicl mice 
injected with thymocytes plus antigen developed draining 
lymph nodes containing lymphocytes (1-2%  of injected T 
cells),  scid mice injected with cells alone or antigen alone, 
however,  failed to develop cellular lymph nodes. Thus, the 
development of lymph nodes was an indicator of the induc- 
tion of an immune response. 0.7-2% of injected B cells were 
recovered from the nodes ofscid mice given B cells and thymo- 
cytes. The number of injected B cells did not appear to en- 
hance the recovery of T  cells in the nodes of reconstituted 
mice: T cell recovery was between 1 and 2% in all sets of  mice. 
Our initial experiments indicated that lymph node cells 
from T  cell-reconstituted scid mice proliferated in vitro to 
KLH, suggesting that T  cells injected into these mice had 
been primed in vivo (data not shown). To further test for 
priming of  T cells in vivo, supematants of KLH-restimulated 
lymph node cells derived from reconstituted scid mice were 
examined for the presence of T cell-derived cytokines. Table 
1, representative of four experiments, indicates that lymph 
node cells derived from scid mice injected with either T cells 
alone or injected with T and B cells secreted comparable levels 
of Ib2,  after restimulation by KLH in vitro. I1-4 was not 
found in the supernatants of any KLH-stimulated  lymph node 
population. 
To compare the composition of the lymph nodes from 
reconstituted scid mice and normal BALB/c mice, FACS  |  anal- 
ysis was performed. In a series of experiments, the percentage 
of CD3 + T cells recovered from the nodes of mice injected 
with 70-100  x  106 thymocytes and varying numbers of B 
cells (up to 50  x  106), and the nodes of primed BALB/c 
mice, were comparable at 60-65%. Similarly, the percentages 
of CD4 + and CD8 + cells were comparable in the nodes of 
scid mice reconstituted with T  cells in the presence  or ab- 
sence of B cells, and normal BALB/c mice.  The results of 
one experiment, representative  of four similar experiments, 
are shown in Fig.  1. scid mice were injected with 100  x  106 
thymocytes in the presence  (V and V/) or absence (III and 
1//) of 15  x  106 B cells. Panel III indicates that fewer than 
1% B cells could be detected in mice injected with purified 
T  cells. Panel IV illustrates that the lymph nodes of such 
T  cell-reconstituted  scid  mice  contain  both  CD4 +  and 
CD8 + cells. Panels V and VI indicate that B cells, as well 
as CD4 + and CD8 + T  cells,  were detected in the lymph 
nodes of mice injected with both thymocytes and B cells. 
The absence of B cells in scid mice injected with thymo- 
cytes alone was confirmed by other criteria.  The response to 
Table  2.  Low levels of Circulating  lg in scid Mice Injected 
with  T  Cells and KLH 
IgM  IgG 
BALB/c 
seidT.v 
scidT  Hv  . m 
scid'mv, zB 
scid 
#g/ml 
1212, 924, 448, 1562  3704,  4198, 704, 2010 
0.5, 0.6, 1.3, 1.5  0.1, 0.1, 4.8, 3.6 
197, 97,  164, 137  31,  12, 420,  625 
150, 126  252, 233 
4.8, 0.1, 0.1, 1.3  0.2,  1.3, 0.5, <0.1 
sc/d mice were injected with 75  x  106 thymocytes  alone  (line 2), thymo- 
cytes +  10  x  10. B calls (line 3), thymocytes + 2 x  10' B cells (line 
4), or no cells (line 5). All mice were killed 9 d after injecting KLH. 
Figures shown are serum levels of individual mice at time of death. In 
BALB/c mice, preinjection  levels of IgM were 2-3 times  lower and IgG 
4-7 times lower than the numbers shown. 
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(data not shown). Moreover, Table 2 indicates that the cir- 
culating levels of IgG and IgM in scid mice that received an- 
tigen and T  cells were as low as background, whereas mice 
injected with both B and T ceils had detectable levels of both 
IgM  and IgG. 
Taken together, these data indicate that unprimed T  cells 
can be primed to KLH in the scid mouse in the absence of 
B cells. As a consequence of priming,  the T  cells proliferate 
and secrete IL-2 in response to KLH in vitro. We therefore 
conclude that  in mice, as in humans  and chickens,  mature 
B cells are not necessary for the induction  of primary im- 
mune responses in vivo. These data suggest that in previous 
studies, in which normal mice were depleted of B cells, the 
antigen-presenting function of cells other than B cells might 
have been affected (6-10). In the set of MHC class II E trans- 
genic mice lacking E expression on B cells, it is also possible 
that  the proliferative response was not  a sensitive assay of 
T cell priming,  as suggested by the authors, since cells from 
only  50%  of the  positive  control  mice responded  to  the 
E-restricted  antigen  (11). 
Our data also confirm the recent finding that mature T 
calls injected into scid mice do not induce B cell differentia- 
tion (14). Although our studies cannot establish which cell 
or cells may be responsible for the induction of primary im- 
mune responses to protein antigens, the previously described 
potency of dendritic cells in inducing T ceU responses makes 
them  strong candidates  (5,  13,  15). 
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